Topical corticosteroid for the treatment of symptoms of seasonal or perennial rhinitis in adult patients, adolescents, and children from 2 years of age. Treatment of symptoms associated with acute rhinosinusitis in patients aged 12 years and older, without symptoms of bacterial infection. Treatment of nasal polyps and associated symptoms.
Mometasone Furoate
Nasal spray suspension
Suspension (nasal spray) Bottle with 18 g (140 applications)
Each application provides approximately 100 mg of aqueous suspension containing 50 μg of mometasone furoate
PF-54732
F028311062015
M-CA-18-00032
102210
